KalVista Pharmaceuticals (4XC1.F) Q2 2023 Earnings

6SepExpected
Sep 21
Q4 2022
Q2 2023
Q2 2023
-0.71
-0.69
-0.68
-0.66

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

KalVista Pharmaceuticals (4XC1.F) will report earnings of for Q2 2023 on September 06, 2023.

0 Comments

Share your thoughts